Nasal delivery systems and their effect on deposition and absorption

被引:162
作者
Kublik, H [1 ]
Vidgren, MT
机构
[1] Astra BmbH, D-22876 Wedel, Germany
[2] Univ Kuopio, Dept Pharmaceut, FI-70211 Kuopio, Finland
[3] AB Draco, S-22100 Lund, Sweden
关键词
nasal drug delivery; device; administration mode; formulation; deposition; distribution; clearance; absorption;
D O I
10.1016/S0169-409X(97)00067-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to nasal anatomy and physiology, with a non-ciliated area in the anterior part of the nasal cavity and a ciliated region in the more posterior part of the nose, the site of deposition is of importance for the nasal mucociliary clearance and retainment of a formulation in the nose. Many drug delivery devices for nasal application of liquid, semisolid and solid formulations were investigated in respect to their deposition in the nasal cavity. The site of deposition and the deposition area depend on several parameters which are related to the delivery device, such as mode of administration, particle size of the formulation and velocity of the delivered particles. Several in vitro and in vivo methods have been used to study distribution and clearance of intranasally delivered therapeutics. The relationship between deposition, absorption and related bioavailability of the nasally applied formulation has been shown. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:157 / 177
页数:21
相关论文
共 72 条
[1]  
AGNEW JE, 1984, AEROSOLS LUNG CLIN E, P127
[2]   DISTRIBUTION AND REMOVAL OF HUMAN-SERUM ALBUMIN TC-99M 99M INSTILLED INTRANASALLY [J].
AOKI, FY ;
CRAWLEY, JCW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (05) :869-878
[3]   THE EFFECT OF SOME PRESERVATIVES USED IN NASAL PREPARATIONS ON MUCOCILIARY CLEARANCE [J].
BATTS, AH ;
MARRIOTT, C ;
MARTIN, GP ;
BOND, SW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (03) :156-159
[4]  
BECQUEMIN MH, 1991, EUR RESPIR J, V4, P694
[5]  
BJORK E, 1993, THESIS UPPSALA U
[6]  
BOND SW, 1985, PROCEEDINGS, V1, P93
[7]  
BORUM P, 1979, SCAND J RESPIR DIS, V60, P253
[8]  
BRAIN J, 1989, PROVOCATIVE CHALLENG, P1
[9]  
BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325
[10]  
BURI P, 1966, PHARM ACTA HELV, V41, P88